SOURCE: SIPP International Industries, Inc.

April 28, 2011 09:00 ET

Le Bon Table Brand Foods Shareholders Agree to Stock Swap With SIPP International Industries, Inc.

LAS VEGAS, NV--(Marketwire - Apr 28, 2011) - Le Bon Table Brand Foods shareholders agreed to a proposal in which SIPP International Industries, Inc. (PINKSHEETS: SIPN) will acquire all remaining outstanding stock that the Las Vegas based company doesn't already own. The vote took place last week at a special meeting of Le Bon Table Administrators and stockholders in Las Vegas, Nevada. Le Bon Table is the manufacturer and holding company of the "Chef Homer" brand of Le Bon Table Gourmet Dinner Entrees, "au" Le Cadeau Natural Mountain Spring Water, the ZCAC Controlled Atmosphere Containers, Newport Creek Hospitality, and Cell Robotics International.

Le Bon Table, once a publicly traded company, became a victim of corporate identity fraud in the latter part of 2009. Immediately thereafter, the company filed criminal complaints in the US Attorney's office in the Southern District of California against William Guest, Mary Bonhage, Artemio Rivera, Alberto Colon and Carolyn Berry. A civil suit was also filed against the individuals in US District Court in the State of Nevada. On recommendation of counsel, the law suit was not pursued to allow for more emphasis on the criminal prosecution.

In December of 2009, Le Bon Table was delisted, leaving the shareholders with worthless stock. By issuing SIPP shares to the Le Bon Table shareholders the founders of Le Bon Table in essence, are giving up controlling interest in the company they created and developed. "I am totally happy for our shareholders," says Le Bon Table founder, Chef H. Lee Thomas Langrill. "They have been tremendously patient throughout this whole ordeal."

In terms of the swap, Le Bon Table shareholders will receive one share of SIPP for every Le Bon Table share owned. SIPP shares are traded on OTC (pinks) under the trading symbol "SIPN." Acting on the recommendation of a special committee of SIPP Administrators appointed by Chairman, Gregg Pearson, the share exchange was endorsed. SIPP has mailed a letter with a warrant certificate to Le Bon Table shareholders detailing instructions of the exchange. SIPP company officials add that Le Bon Table shareholders rather than owning a minority interest in a fledgling, delisted company, will instead own a solid percentage in a global company which currently owns and manufactures the Cell Robotics "Lasette."

Cell Robotics is a wholly owned subsidiary of SIPP (www.sippiii.com) which is the manufacturer and marketer of medical and scientific laser devices. The award winning Lasette is a miniature laser finger perforator, slightly larger than a cell phone that allows for the testing of blood glucose levels with absolute minimal pain, no lingering soreness and less residual bleeding. Because it completely eliminates the need to use steel lancets, it also makes obtaining blood samples more easily for needle phobic's and especially more gentle for children. Recent manufacturing improvements to the "Lasette" have resulted in a Personal Lasette which may be used in both home and clinical environments. The only adaptation required is a change out of a protective disposable cartridge once used in clinical applications. The recent improvements have resulted in a Lasette that is more robust and will withstand the heavy usage requirements in the clinical setting. SIPP closed today at a share price of $2.75.

"This press release contains statements which address such key issues as to SIPP International Industries, Inc. growth strategies, future financial results, market positions, product development, pharmaceutical products in the pipeline, and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, progress of drug development, clinical testing and regulatory approval, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies."

Contact Information